{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:48:58Z","timestamp":1762174138992,"version":"build-2065373602"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhu Xiu Shan Talent Project of Ningbo No.2 Hospital","award":["2023HMJQ05"],"award-info":[{"award-number":["2023HMJQ05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03643-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:52:50Z","timestamp":1762167170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of biomarkers related to the progression of cutaneous melanoma and construction of survival prognosis model"],"prefix":"10.1007","volume":"16","author":[{"given":"Kana","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longjun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"6","key":"3643_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/pcmr.12412","volume":"28","author":"MR Roh","year":"2015","unstructured":"Roh MR, Eliades P, Gupta S, Tsao H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 2015;28(6):661\u201372.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"24","key":"3643_CR2","first-page":"02878","volume":"8","author":"D Aldea","year":"2024","unstructured":"Aldea D, Macagno N, Marechal E, Moreno M, Romanet P, Pertuit M, Garcia J, Degardin N, Mallet S, James I, et al. Deconvoluted methylation profiles discriminate between closely related melanocytic nevi. J Invest Dermatol. 2024;8(24):02878\u201302871.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3643_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1346-8138.14737","volume":"46","author":"T Saida","year":"2019","unstructured":"Saida T. Histogenesis of cutaneous malignant melanoma: the vast majority do not develop from melanocytic nevus but arise de Novo as melanoma in situ. J Dermatol. 2019;46(2):80\u201394.","journal-title":"J Dermatol"},{"key":"3643_CR4","doi-asserted-by":"crossref","unstructured":"T\u00edm\u00e1r J, Lad\u00e1nyi A. Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 2022, 23(10).","DOI":"10.3390\/ijms23105384"},{"issue":"3","key":"3643_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jmir.2019.05.001","volume":"50","author":"D Burns","year":"2019","unstructured":"Burns D, George J, Aucoin D, Bower J, Burrell S, Gilbert R, Bower N. The pathogenesis and clinical management of cutaneous melanoma: an Evidence-Based review. J Med Imaging Radiation Sci. 2019;50(3):460\u2013e469461.","journal-title":"J Med Imaging Radiation Sci"},{"issue":"2","key":"3643_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.coms.2021.12.001","volume":"34","author":"AM Bunnell","year":"2022","unstructured":"Bunnell AM, Nedrud SM, Fernandes RP. Classification and staging of melanoma in the head and neck. Oral Maxillofac Surg Clin N Am. 2022;34(2):221\u201334.","journal-title":"Oral Maxillofac Surg Clin N Am"},{"key":"3643_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-031-27156-4_10","volume":"185","author":"RF Saeed","year":"2023","unstructured":"Saeed RF, Awan UA, Saeed S, Mumtaz S, Akhtar N, Aslam S. Targeted therapy and personalized medicine. Cancer Treat Res. 2023;185:177\u2013205.","journal-title":"Cancer Treat Res"},{"issue":"42","key":"3643_CR8","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1038\/onc.2017.189","volume":"36","author":"WE Damsky","year":"2017","unstructured":"Damsky WE, Bosenberg M. Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene. 2017;36(42):5771\u201392.","journal-title":"Oncogene"},{"issue":"6","key":"3643_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","volume":"9","author":"W Wagstaff","year":"2022","unstructured":"Wagstaff W, Mwamba RN, Grullon K, Armstrong M, Zhao P, Hendren-Santiago B, Qin KH, Li AJ, Hu DA, Youssef A, et al. Melanoma: molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance. Genes Dis. 2022;9(6):1608\u201323.","journal-title":"Genes Dis"},{"key":"3643_CR10","doi-asserted-by":"crossref","unstructured":"Dessinioti C, Befon A, Stratigos AJ. The association of Nevus-Associated melanoma with common or dysplastic melanocytic nevus: A systematic review and Meta-Analysis. Cancers 2023, 15(3).","DOI":"10.3390\/cancers15030856"},{"issue":"7","key":"3643_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Genomic Classification of Cutaneous Melanoma","year":"2015","unstructured":"Genomic Classification of Cutaneous Melanoma. Cell. 2015;161(7):1681\u201396.","journal-title":"Cell"},{"issue":"1","key":"3643_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.celrep.2016.03.006","volume":"15","author":"YV Katlinskaya","year":"2016","unstructured":"Katlinskaya YV, Katlinski KV, Yu Q, Ortiz A, Beiting DP, Brice A, Davar D, Sanders C, Kirkwood JM, Rui H, et al. Suppression of type I interferon signaling overcomes Oncogene-Induced senescence and mediates melanoma development and progression. Cell Rep. 2016;15(1):171\u201380.","journal-title":"Cell Rep"},{"issue":"1","key":"3643_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccell.2014.11.014","volume":"27","author":"W Damsky","year":"2015","unstructured":"Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, et al. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell. 2015;27(1):41\u201356.","journal-title":"Cancer Cell"},{"issue":"3","key":"3643_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.23736\/S2784-8671.21.06958-3","volume":"156","author":"M Bobos","year":"2021","unstructured":"Bobos M. Histopathologic classification and prognostic factors of melanoma: a 2021 update. Italian J Dermatology Venereol. 2021;156(3):300\u201321.","journal-title":"Italian J Dermatology Venereol"},{"issue":"1","key":"3643_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.hoc.2020.08.010","volume":"35","author":"SM Ostrowski","year":"2021","unstructured":"Ostrowski SM, Fisher DE. Biology of melanoma. Hematol Oncol Clin N Am. 2021;35(1):29\u201356.","journal-title":"Hematol Oncol Clin N Am"},{"key":"3643_CR16","doi-asserted-by":"crossref","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci (Basel Switzerland) 2021, 9(4).","DOI":"10.3390\/medsci9040063"},{"issue":"6","key":"3643_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The Sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"3643_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s11658-022-00353-5","volume":"27","author":"D Suwei","year":"2022","unstructured":"Suwei D, Yanbin X, Jianqiang W, Xiang M, Zhuohui P, Jianping K, Yunqing W, Zhen L. Metformin inhibits melanoma cell metastasis by suppressing the miR-5100\/SPINK5\/STAT3 axis. Cell Mol Biol Lett. 2022;27(1):48. https:\/\/doi.org\/10.1186\/s11658-022-00353-5.","journal-title":"Cell Mol Biol Lett"},{"issue":"14","key":"3643_CR19","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.18632\/oncotarget.3655","volume":"6","author":"H Cirenajwis","year":"2015","unstructured":"Cirenajwis H, Ekedahl H, Lauss M, Harbst K, Carneiro A, Enoksson J, Rosengren F, Werner-Hartman L, T\u00f6rngren T, Kvist A, et al. Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy. Oncotarget. 2015;6(14):12297\u2013309.","journal-title":"Oncotarget"},{"issue":"7","key":"3643_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):20.","journal-title":"Nucleic Acids Res"},{"issue":"559","key":"3643_CR21","first-page":"1471","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(559):1471\u20132105.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3643_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"L Kumar","year":"2007","unstructured":"Kumar L. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007;2(1):5\u20137.","journal-title":"Bioinformation"},{"issue":"1","key":"3643_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"D1","key":"3643_CR24","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3643_CR25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"3643_CR26","first-page":"1752","volume":"4","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;4(Suppl 4):1752\u20130509.","journal-title":"BMC Syst Biol"},{"key":"3643_CR27","doi-asserted-by":"crossref","unstructured":"Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K, Huang Q, Shi X, Ni Z, Ding N et al. Tumor-Infiltrating immune cells act as a marker for prognosis in colorectal cancer. Front Immunol 2019, 10(2368).","DOI":"10.3389\/fimmu.2019.02368"},{"issue":"34","key":"3643_CR28","doi-asserted-by":"publisher","first-page":"55343","DOI":"10.18632\/oncotarget.10533","volume":"7","author":"P Wang","year":"2016","unstructured":"Wang P, Wang Y, Hang B, Zou X, Mao JH. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer. Oncotarget. 2016;7(34):55343\u201351.","journal-title":"Oncotarget"},{"issue":"4","key":"3643_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The Lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"issue":"77","key":"3643_CR30","first-page":"1471","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(77):1471\u20132105.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"3643_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"key":"3643_CR32","doi-asserted-by":"crossref","unstructured":"Shan S, Chen W, Jia JD. Transcriptome analysis revealed a highly connected gene module associated with cirrhosis to hepatocellular carcinoma development. Front Genet 2019, 10(305).","DOI":"10.3389\/fgene.2019.00305"},{"key":"3643_CR33","doi-asserted-by":"crossref","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol 2018:7493\u201374917412.","DOI":"10.1007\/978-1-4939-7493-1_12"},{"issue":"4","key":"3643_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351\u20139.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3643_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/onc.2016.198","volume":"36","author":"BI Ratnikov","year":"2017","unstructured":"Ratnikov BI, Scott DA, Osterman AL, Smith JW, Ronai ZA. Metabolic rewiring in melanoma. Oncogene. 2017;36(2):147\u201357.","journal-title":"Oncogene"},{"key":"3643_CR36","doi-asserted-by":"crossref","unstructured":"Yahsi B, Gunaydin G. Immunometabolism - The role of Branched-Chain amino acids. Front Immunol 2022, 13(886822).","DOI":"10.3389\/fimmu.2022.886822"},{"issue":"7","key":"3643_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016;48(7):81.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3643_CR38","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1159\/000533806","volume":"66","author":"O Deliktas","year":"2023","unstructured":"Deliktas O, Gedik ME, Koc I, Gunaydin G, Kiratli H. Modulation of AMPK significantly alters uveal melanoma tumor cell viability. Ophthalmic Res. 2023;66(1):1230\u201344.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"3643_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/138161210789941865","volume":"16","author":"A Carnero","year":"2010","unstructured":"Carnero A. The PKB\/AKT pathway in cancer. Curr Pharm Des. 2010;16(1):34\u201344.","journal-title":"Curr Pharm Des"},{"issue":"21","key":"3643_CR40","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1007\/s00018-013-1324-2","volume":"70","author":"T Regad","year":"2013","unstructured":"Regad T. Molecular and cellular pathogenesis of melanoma initiation and progression. Cell Mol Life Sci. 2013;70(21):4055\u201365.","journal-title":"Cell Mol Life Sci"},{"key":"3643_CR41","first-page":"244","volume":"2","author":"MR Webster","year":"2015","unstructured":"Webster MR, Kugel CH 3rd, Weeraratna AT. The Wnts of change: how Wnts regulate phenotype switching in melanoma. Biochim Biophys Acta. 2015;2:244\u201351.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"3643_CR42","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1158\/1535-7163.MCT-07-2263","volume":"7","author":"J Fukai","year":"2008","unstructured":"Fukai J, Yokote H, Yamanaka R, Arao T, Nishio K, Itakura T. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Mol Cancer Ther. 2008;7(9):2768\u201378.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"3643_CR43","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1158\/1535-7163.MCT-12-0030","volume":"11","author":"P Saintigny","year":"2012","unstructured":"Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman SM, Girard L, Minna JD, Heymach JV, Johnson FM. Global evaluation of Eph receptors and Ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther. 2012;11(9):2021\u201332.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3643_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/0008-5472.CAN-17-1933","volume":"78","author":"KT Hua","year":"2018","unstructured":"Hua KT, Hong JB, Sheen YS, Huang HY, Huang YL, Chen JS, Liao YH. miR-519d promotes melanoma progression by downregulating EphA4. Cancer Res. 2018;78(1):216\u201329.","journal-title":"Cancer Res"},{"key":"3643_CR45","doi-asserted-by":"crossref","unstructured":"Pergaris A, Danas E, Gajdzis P, Levidou G, Gajdzis M, Cassoux N, Gardrat S, Donizy P, Korkolopoulou P, Kavantzas N et al. EPHA2, EPHA4, and EPHA6 expression in uveal melanomas: searching for the culprits of neoplasia. Diagnostics 2022, 12(5).","DOI":"10.3390\/diagnostics12051025"},{"issue":"3","key":"3643_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1755-148X.2011.00834.x","volume":"24","author":"L Sommer","year":"2011","unstructured":"Sommer L. Generation of melanocytes from neural crest cells. Pigment Cell Melanoma Res. 2011;24(3):411\u201321.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"3643_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/PAI.0b013e318279bc0a","volume":"21","author":"A Mohamed","year":"2013","unstructured":"Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C. SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol. 2013;21(6):506\u201310.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"8","key":"3643_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ncb2535","volume":"14","author":"O Shakhova","year":"2012","unstructured":"Shakhova O, Zingg D, Schaefer SM, Hari L, Civenni G, Blunschi J, Claudinot S, Okoniewski M, Beermann F, Mihic-Probst D, et al. Sox10 promotes the formation and maintenance of giant congenital Naevi and melanoma. Nat Cell Biol. 2012;14(8):882\u201390.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3643_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/DAD.0000000000002018","volume":"44","author":"RJ Straker","year":"2022","unstructured":"Straker RJ 3rd, Taylor LA, Neuwirth MG, Sinnamon AJ, Shannon AB, Abbott J, Miura JT, Chu EY, Xu X, Karakousis GC. Optimizing detection of lymphatic invasion in primary cutaneous melanoma with the use of D2-40 and a paired melanocytic marker. Am J Dermatopathol. 2022;44(1):21\u20137.","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"3643_CR50","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12094-015-1469-6","volume":"18","author":"JA Guadarrama-Orozco","year":"2016","unstructured":"Guadarrama-Orozco JA, Ortega-G\u00f3mez A, Ruiz-Garc\u00eda EB, Astudillo-de la Vega H, Meneses-Garc\u00eda A, Lopez-Camarillo C. Braf V600E mutation in melanoma: translational current scenario. Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2016;18(9):863\u201371.","journal-title":"Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"12","key":"3643_CR51","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1631\/jzus.B2200285","volume":"23","author":"S Jiang","year":"2022","unstructured":"Jiang S, Zhang W, Lu Y. Development and validation of novel inflammatory response-related gene signature for sepsis prognosis. J Zhejiang Univ Sci B. 2022;23(12):1028\u201341.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"15","key":"3643_CR52","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.7150\/ijbs.65669","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xia P, Liu J, Chen Z, Ma W, Yuan Y. ATIC inhibits autophagy in hepatocellular cancer through the AKT\/FOXO3 pathway and serves as a prognostic signature for modeling patient survival. Int J Biol Sci. 2021;17(15):4442\u201358.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"3643_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41416-018-0167-x","volume":"119","author":"NB Wagner","year":"2018","unstructured":"Wagner NB, Forschner A, Leiter U, Garbe C, Eigentler TK. S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies. Br J Cancer. 2018;119(3):339\u201346.","journal-title":"Br J Cancer"},{"key":"3643_CR54","doi-asserted-by":"publisher","first-page":"772165","DOI":"10.3389\/fonc.2021.772165","volume":"11","author":"EA Janka","year":"2021","unstructured":"Janka EA, V\u00e1rv\u00f6lgyi T, Sipos Z, So\u00f3s A, Hegyi P, Kiss S, Dembrovszky F, Csupor D, K\u00e9ringer P, P\u00e9csi D, et al. Predictive performance of serum S100B versus LDH in melanoma patients: A systematic review and Meta-Analysis. Front Oncol. 2021;11:772165.","journal-title":"Front Oncol"},{"issue":"32","key":"3643_CR55","doi-asserted-by":"publisher","first-page":"e29536","DOI":"10.1097\/MD.0000000000029536","volume":"101","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu B, Kotenko S, Li W. Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Medicine. 2022;101(32):e29536.","journal-title":"Medicine"},{"key":"3643_CR56","doi-asserted-by":"crossref","unstructured":"Das S, Camphausen K, Shankavaram U. Cancer-Specific immune prognostic signature in solid tumors and its relation to immune checkpoint therapies. Cancers 2020, 12(9).","DOI":"10.3390\/cancers12092476"},{"issue":"2","key":"3643_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1309\/WAVR-560R-NU5E-4Q96","volume":"115","author":"RT Vollmer","year":"2001","unstructured":"Vollmer RT, Seigler HF. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma. Am J Clin Pathol. 2001;115(2):205\u201312.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"3643_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/phpp.12770","volume":"38","author":"L Ding","year":"2022","unstructured":"Ding L, Gosh A, Lee DJ, Emri G, Huss WJ, Bogner PN, Paragh G. Prognostic biomarkers of cutaneous melanoma. PhotoDermatol PhotoImmunol PhotoMed. 2022;38(5):418\u201334.","journal-title":"PhotoDermatol PhotoImmunol PhotoMed"},{"issue":"6","key":"3643_CR59","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jaad.2022.08.052","volume":"87","author":"X Wei","year":"2022","unstructured":"Wei X, Chen Y, Yao H, Wu D, Li H, Zhang R, Chi Z, Cui C, Bai X, Mao L, et al. Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis. J Am Acad Dermatol. 2022;87(6):1287\u201394.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"3643_CR60","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1097\/01.pas.0000213262.61855.7d","volume":"30","author":"H Grande Sarpa","year":"2006","unstructured":"Grande Sarpa H, Reinke K, Shaikh L, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M. Prognostic significance of extent of ulceration in primary cutaneous melanoma. Am J Surg Pathol. 2006;30(11):1396\u2013400.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3643_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/CCO.0b013e32834fcb0d","volume":"24","author":"AM Eggermont","year":"2012","unstructured":"Eggermont AM, Spatz A, Lazar V, Robert C. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity? Curr Opin Oncol. 2012;24(2):137\u201340.","journal-title":"Curr Opin Oncol"},{"key":"3643_CR62","doi-asserted-by":"crossref","unstructured":"Ferroni P, Zanzotto FM, Riondino S, Scarpato N, Guadagni F, Roselli M. Breast cancer prognosis using a machine learning approach. Cancers 2019, 11(3).","DOI":"10.3390\/cancers11030328"},{"key":"3643_CR63","doi-asserted-by":"crossref","unstructured":"Bossard C, Salhi Y, Khammari A, Brousseau M, Le Corre Y, Salhi S, Qu\u00e9reux G, Chetritt JJ. Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning. J Eur Acad Dermatology Venereology: JEADV 2025.","DOI":"10.1111\/jdv.20538"},{"issue":"8","key":"3643_CR64","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-023-06068-5","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Bai Y, Ma XX, Song JK, Luo Y, Fei XY, Ru Y, Luo Y, Jiang JS, Zhang Z, et al. Clinical-mediated discovery of pyroptosis in CD8(+) T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence. Cell Death Dis. 2023;14(8):553.","journal-title":"Cell Death Dis"},{"key":"3643_CR65","doi-asserted-by":"crossref","unstructured":"Wang T, Feldman GM, Herlyn M, Kaufman RE. The macrophage: switches from a passenger to a driver during anticancer therapy. Oncoimmunology 2015, 4(12).","DOI":"10.1080\/2162402X.2015.1052929"},{"issue":"7","key":"3643_CR66","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1080\/21645515.2017.1312043","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Yang L, Wang D, Zhang Q, Zhang L. Pro-tumor activities of macrophages in the progression of melanoma. Hum Vaccin Immunother. 2017;13(7):1556\u201362.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"3643_CR67","doi-asserted-by":"publisher","first-page":"023","DOI":"10.1038\/s41419-023-06068-5","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Bai Y, Ma XX, Song JK, Luo Y, Fei XY, Ru Y, Jiang JS, Zhang Z, Yang D, et al. Clinical-mediated discovery of pyroptosis in CD8(+) T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence. Cell Death Dis. 2023;14(8):023\u201306068.","journal-title":"Cell Death Dis"},{"key":"3643_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03643-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:08:10Z","timestamp":1762171690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03643-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3643"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03643-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was in accordance with the national legislation and the Declaration of Helsinki, and was approved by the Institutional Ethics Committee of Ningbo NO.2 Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2013"}}